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Abstract: Affecting a large percentage of human population herpes simplex virus (HSV) types -1 and -2 mainly cause 
oral, ocular, and genital diseases. Infection begins with viral entry into a host cell, which may be preceded by viral 
“surfing” along filopodia. Viral glycoproteins then bind to one or more of several cell surface receptors, such as 
herpesvirus entry mediator (HVEM), nectin-1, 3-O sulfated heparan sulfate (3-OS HS), paired immunoglobulin-like 
receptor , and non-muscle myosin-IIA. At least five viral envelope glycoproteins participate in entry and these include 
gB, gC, gD and gH-gL. Post-entry, these glycoproteins may also facilitate cell-to-cell spread of the virus, which helps in 
the evasion of physical barriers as well as several components of the innate and adaptive immune responses. The spread 
may be facilitated by membrane fusion, movement across tight junctions, transfer across neuronal synapses, or the 
recruitment of actin-containing structures. This review summarizes some of the recent advances in our understanding of 
HSV entry and cell-to-cell spread. 
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INTRODUCTION 
 The herpesviridae family consists of over 70 viral 
species, eight of which, herpes simplex virus-1 (HSV-1), 
herpes simplex virus-2 (HSV-2), varicella-zoster virus 
(VZV), cytomegalovirus (CMV), human herpesvirus 6 
(HHV-6), human herpesvirus 7 (HHV-7), human herpesvirus 
8 (HHV-8) and Epstein-Barr virus, are pathogenic to humans 
and may infect anywhere from thirty to over ninety percent 
of the adult human population [1]. Herpesviruses are 
characterized by linear, double-stranded DNA enclosed in 
icosahedral capsids. About 15-20 tegument proteins enclose 
the capsid, as well as a lipid bilayer membrane envelope 
derived from host cells [2]. All herpes viruses enter into 
latency after primary infection, establishing infection for the 
lifetime of their hosts. From their latency, herpesviruses can 
be reactivated, which has been correlated with a weakening 
of a host’s immune defenses against the virus, to cause 
various diseases [3]. These diseases often involve viral 
shedding, or are contagious, allowing the spread of a specific 
herpesvirus within a population. 
 Affecting a significant majority of the general populace, 
herpes simplex virus 1 (HSV-1) represents one of the most 
studied herpesviruses. It causes mainly oral and ocular 
manifestations. Facial herpes causes an annual 500,000 cases 
of herpes labialis, HSV infection of the lips, mouth, gums or 
lip area [3]. After primary infection, HSV-1 enters periods of  
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latency in the trigeminal or cervical ganglia, where it can be 
reactivated to cause recurrent episodes of viral shedding at 
the skin through lesions and sores. Asymptotic viral 
shedding can also occur, as it was reported in over 90% of 
adults and often the virus was shed without an indication of 
shedding through a lesion or sore [4]. One can contract 
HSV-1 through direct contact with sites of viral shedding, or 
with mucocutaneous fluids, which can also carry the virus 
[4]. Diseases caused by HSV-1 in the throat and mouth 
include pharyngitis, tonsillitis, and gingivostomatitis, which 
cause inflammation of pharynx and tonsils and swelling of 
the gums [2]. Ocular HSV-1 infections lead to several 
conditions, including stromal keratitis, blepharitis and 
retinitis, which are inflammations of the cornea, eyelid and 
retinarespectively [5]. In addition, immunocompromised 
hosts can suffer from HSV encephalitis, visceral infections 
including but not limited to pneumonitis, esophagitis, and 
hepatitis. 
 HSV-2 affected 45 million people aged 14 years or above 
in the United States alone and is the leading cause of 
recurrent genital herpes cases worldwide [6]. Genital herpes 
is characterized by painful ulcerated lesions and sores on the 
genitalia, although it can be asymptotic as well. Genital 
herpes increases the risk of contracting HIV by 2 or 3 times, 
as it is believed that 40-60% of HIV patients show prior 
infection with HSV-2 [6]. Schacker et al. repeatedly detected 
HIV RNA in genital ulcers, while they reported a decrease in 
HIV viral shedding with the healing of Genital Ulcer Disease 
(GUD) [7]. Recurrent genital herpes is mainly caused by 
HSV-2, as HSV-1 is less likely to be reactivated from the 
sacral ganglia, where HSV-2 latency and reactivation occurs 
[7]. Similar to HSV-1, HSV-2 can be contracted through 
direct contact with sites of viral shedding, which occurs after 
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reactivation of the virus from its latency in sacral ganglia. 
Therefore, shedding of the virus from genital areas during 
sexual intercourse is the main method of contracting or 
spreading the virus [8]. 
 However, there are additional methods of contracting 
HSV-2 as well. Recent studies have placed emphasis on the 
transfer of mainly HSV-2, but also HSV-1, from mother to 
child. The most common method of vertical transfer of HSV 
occurs during child birth through contact with an infected 
birth canal. Neonates can also contract HSV through contact 
with an HSV-infected caregiver or through ingestion of 
infected maternal secretions, known as intrauterine 
infections [9]. Neonatal infections by HSV-2 or HSV-1 pose 
serious threats, as they often lead to fatal diseases. These 
include SEM disease (disease located in the skin, eye or 
mouth), herpes encephalitis, or dispersed multi-organ 
infection [10]. HSV-2 can cause meningitis in neonates, 
which is usually more severe and life-threatening than 
Mollaret meningitis. The latter is a rare form of recurrent 
meningitis also caused by HSV-2 in adults. Unlike neonatal 
meningitis, it is aseptic, mild, and usually self-limiting. 
 HSV holds several factors that allow it to evade the 
immune system, leading to chronic infection in the body. 
HSV-1 glycoprotein gC binds C3b of the complement 
cascade, preventing the formation of anaphylatoxin C5a, as 
well as the formation of the Membrane attack complex 
(MAC) [11]. MAC is normally responsible for disrupting the 
phospholipid bilayer of infected cells, leading to cell lysis 
and death. Also, The HSV-1 gene ICP47 binds to the peptide 
transporter associated with antigen presentation, leading to 
the prevention of peptides on the major histocompatibility 
complex 1 (MHC1), thereby inhibiting the presentation of 
viral antigens to cytotoxic T-cells [12]. Other virulence 
factors include the gE-gI heterodimer, as well as viral host 
shutoff protein (vhs). Vhs has several functions, which 
include the prevention of production of IFN-, which works 
with cytokines in intercellular signaling as well and plays a 
role in antiviral response, through the reduced IRF7 
activation. Additionally, vhs is able to suppress 
proinflammatory cytokines and chemokines, inhibit antigen 
presentation by MHCI and MHCII, and inhibit the 
maturation of dendritic cells. The glycoproteins gE-gI have 
been shown to inhibit the activation of the complement 
cascade by binding to the Fc domain on IgG of antibodies 
which activate the classical complement cascade [13]. 
Methods by which the virus enter host-cells and the 
machinery that allow the virus to evade immune defenses, 
including cell-to-cell spread, help establish lifelong infection 
by HSV-1 and HSV-2. 
ENTRY 
 HSV-1 and HSV-2 utilize several glycoprotein-receptor 
complexes when entering into host cells (Fig. 1). Both 
express the glycoproteins gB, gC, gD, gH, and gL. All 
except gC are essential for host cell entry, although the 
absence of gC does reduce efficiency [1]. gC makes the first 
contact with the host cell, binding to heparan sulfate (HS) 
proteoglycans on the cell surface. In the absence of gC, gB is 
able to carry out this function. HSV-1 has been shown to 
exercise several methods to attach to the host cell. In some 
cases, HSV-1 travels down filopodia-like membrane 
protrusions to reach the cell body for internalization. This 
extracellular transport of virions is called “surfing”(Fig. 1) 
[14]. Exposure to HSV-1 can induce the formation of these 
actin-rich, filopodia-like structures by the cell. This is 
facilitated through members of the Rho GTPase family, 
which have been shown to act as a link between surface 
receptors such as syndecans or integrins and the actin 
cytoskeleton organization underneath [15, 16]. At the 
activation of these small GTPases, filopodia are formed. The 
glycoprotein gB seems to regulate viral surfing, as it binds to 
the HS expressed on the filopodia. Once the virus is bound, 
it travels unilaterally to the cell surface, where gD proceeds 
to bind with one of its four receptors (discussed below) and 
the process of virus penetration and membrane fusion ensues 
[14, 16-18]. 
GLYCOPROTEINS AND RECEPTORS IMPORTANT 
FOR ENTRY 
 The glycoproteins gB and gH play a significant role in 
membrane fusion, allowing the lipids in both the viral and 
cell membranes to mix. Of all the glycoproteins involved in 
entry, gB is the most conserved and is likely to function as a 
membrane fusogen [19]. As a fusogenic protein it is quite 
unique and has not been classified as either a class I or class 
II fusion protein. In fact, it contains characteristics of both 
classes; namely, an -helical coiled-coil core and extended  
hairpins [19]. In addition, multiple domains play crucial 
roles in the functioning of gB [20]. Without gL, gH is only 
poorly expressed at the cell surface and it may be structurally 
immature [21, 22]. gL, therefore, has been implicated as a 
kind of guide for gH, so that the latter is able to carry out its 
function in cell entry [22]. The main purpose of gD is to bind 
to a receptor on the cell surface to induce viral fusion to the 
cell membrane [2, 23]. At the core of gD is a V-shaped 
immunoglobulin domain and its flexible N-terminus folds 
into a hairpin-like structure. Several residues on the C-
terminus of gD regulate receptor binding [23, 24]. 
 gD can use three different families of receptors to enter 
into uninfected cells (Table 1). Herpesvirus entry mediator, 
or HVEM, is one such receptor that aids in entry along with 
its normal function within the tumor necrosis factor receptor 
(TNFR) superfamily as a part of the process of apoptosis. 
Normally, HVEM binds to LIGHT, a member of the tumor 
necrosis factor (TNF) superfamily that activated T cells 
express [25]. Nectin-1 and nectin-2, affiliated with the 
immunoglobulin (Ig) family, have also been shown to act as 
receptors [2]. Generally, these relatives of the poliovirus 
receptor play a role in cell adhesion. While four nectins have 
been discovered, only the aforementioned two can act as 
receptors for HSV gD [26]. Finally, 3-O sulfated heparan 
sulfate (3-OS-HS), a polysaccharide belonging to the HS 
family and thus consisting of a basic structure of repeating 
disaccharide units, can be used for entry [27-30]. However, 
only specific isoforms of 3-OS-HS, resulting from the action 
of certain 3-O-sulfotransferases, are able to bind to gD [27]. 
 The receptors have been found to be specific to certain 
types of cells. For example, nectin-1 is generally used by 
herpesviruses entering epithelial cells [2]. In activated T-
lymphocytes or Trabecular meshwork cells of the eye, 
HVEM is the major receptor [26, 31]. In addition, the type of 
virus can influence the receptor used. Nectin-2 has not 
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shown significant results in helping wild-type HSV-1 entry, 
while HSV-2 does not seem to use 3-OS HS [1, 26]. gB, on 
the other hand, can use paired immunoglobulin-like receptor 
alpha (PILR-) as a coreceptor for cell entry [32]. While 
both types of the herpesvirus may use this receptor, it has 
been proved ineffectual for HSV-2 [33]. In addition, the 
binding of gB to PILR- may aid in evading the immune 
system by sending inhibitory signals to the host cell. 
Recently gB was also shown to bind non-muscle myosin 
heavy chain IIA [34]; however, a clear significance of this 
interaction is not well established. Furthermore, similar to 
gB, gH also has two receptors that may aid in entry. B5, 
which is a type 2 membrane protein that is able to form an -
helix for coiled-coils, can interact with other proteins 
containing -helices such as HSV-1 gH, which may help it 
facilitate HSV-1 fusion [35]. The functional effect on HSV 
entry of the second possible receptor for gH, v3 integrins, 
has not yet been well understood [36]. 
 Likewise, very limited information is available on the 
role of entry receptors in HSV-1 endocytosis [37]. Some  
 
Table 1. Cell Lines with Known gD Receptors 
 
Cell Line (Virus) Major Entry 
Receptor 
Human conjunctival epithelium (HSV-1) Nectin-1, HVEM 
Human corneal fibroblasts, primary (HSV-1) 3-OS HS 
Human corneal fibroblasts, primary (HSV-2) HVEM 
Human corneal epithelium (HSV-1) Nectin-1 
Human Mesenchymal Stem Cells (HSV-1) 3-OS HS 
Human Trabecular Meshwork Cells, primary (HSV-1) HVEM 
HeLa Cells (HSV-1, HSV-2) Nectin-1, HVEM 
Retinal pigment epithelial cells (HSV-1) Nectin-1 
Retinal pigment epithelial cells (HSV-2) Nectin-1 
Radial glial cells and Cajal-Retzius cells  Nectin-1 
Neuronal cells (HSV-1, HSV-2) Nectin-1 
 
 
Fig. (1). Genomic distribution of HSV glycoproteins involved in viral entry and cell-to-cell spread. A. Glycoprotein genes required for HSV-
1 entry and spread. HSV contains a 152-kb double-stranded linear DNA genome encoding over 80 viral genes that are arranged as unique 
long (UL) and unique short (US) segments flanked by inverted repeat sequences (boxes). The inverted repeats contain sequences required for 
cleavage/packaging of the viral genome. The genes encoding glycoproteins important for HSV-1 entry and spread are shown. B. Pathways of 
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recent studies have suggested that HSV-1 can induce 
primary human corneal fibroblasts to engulf it in a form of 
an atypical endocytosis. Because this method may not be pH 
dependent and does not involve the use of clathrin-coated 
vesicles or caveolae, the uptake of HSV into cells most 
closely resembles phagocytosis [15]. This method may also 
need actin rearrangement and dynamin assembly to function, 
as well as the work of RhoA, a member of the Rho GTPase 
family, and some PI3 kinases [15, 38]. As aforementioned, 
HSV-1 induces the formation of protrusions from the cell 
surface. Association with these protrusions, as well as the 
clustering of gD receptors in large vesicles, marks this form 
of uptake [15]. It is quite likely that the virus then fuses with 
the membrane of an intra-cellular vesicle to release its capsid 
into the cytosol [15]. Recently, it was demonstrated that 
virus-cell fusion is also facilitated by syndecan-1 and 
syndecan-2 proteoglycan core proteins, as it was found that 
down-regulation of syndecan-1 and syndecan-2 led to a 
statistically significant decrease in HSV-1 entry and 
membrane fusion [39]. Since syndecans have been 
implicated in endocytosis [40] it is possible that they help 
with the virion fusion at a vesicular membrane. HSV-1 
internalization via endosomes may allow virus to enter by 
both ways, fusion of the viral envelope at the plasma 
membrane and also by endocytosis. HSV-1 shows a very 
broad host range and quite possibly, it may have evolved 
versatile ways to enter into its multiple host cell-types. 
 Post fusion, the nucleocapsid and tegument proteins of 
the virus are released into the cytoplasm of the cell through 
the fusion pore. They are aided in their travel to the nucleus 
by the dynein-dynactin protein complex, which some viral 
tegument proteins may also take part in. The viral capsid 
contains VP26, which interacts with two dynein light chains: 
Tctex1 and rp3. VP26 attracts dynein to the viral capsid, 
which then transports the virus along the microtubules (MT) 
of the cell [41]. The virus is taken first to the microtubule 
organizing center (MTOC) and then to the nucleus itself, 
where it binds to the nuclear pore complexes (NPCs). The 
viral DNA is released through these pores into the nucleus, 
where viral replication will occur [41]. 
CELL-TO-CELL SPREAD 
 HSV-1 has the ability to use cell-to-cell spread to transfer 
the virus between infected and uninfected cells. Rather than 
using incessant infection of host epithelial and lymphocytic 
cells to reproduce for more infection, cell-to-cell spread uses 
various methods, including cell-to-cell fusion, virion fusion 
across tight junctions, transfer across synapses and the 
recruitment of actin-containing structures to spread the virus 
directly from an infected to an uninfected cell. Proposals for 
how these phenomena occur have been supported by studies 
aimed to identify molecular details of the events. 
 Cell-to-cell fusion involves the fusion of plasma 
membranes of infected and uninfected cells to form a 
syncytial cell. However, a “microfusion” can occur where 
the two cells fuse but remain structurally independent. 
Theoretically, any cell with machinery needed for virus-cell 
fusion can undergo cell-to-cell fusion with an infected cell. 
The binding of HSV glycoprotein gD on an infected cell to 
its receptors on uninfected cells is essential to both virus-cell 
and cell-to-cell fusion [42-44]. In addition to gB, gH-gL, 
other glycoproteins including gE and gL, have been found as 
essential to the process, as gE and gL form a heterodimer in 
the trans-Golgi network (TGN) necessary for fusion of 
epithelial cells, which can be halted by a disruption of early 
sorting through the TGN [45]. Additionally, gK was found to 
be a vital component of cell-to-cell fusion in corneal and 
trigeminal ganglia cells, as mice infected with HSV-1 
lacking gK displayed a significant decrease in cell-to-cell 
fusion [46]. 
 Several gD receptors have been shown to play roles in 
cell-to-cell fusion, including HVEM, nectin-1 and 3-OS-HS. 
Tiwari et al. found 3-O sulfated heparan sulfate to mediate 
cell-to-cell fusion, as cells lacking the receptor showed a 
significant decrease in cell-to-cell fusion [47]. O’Donnell & 
Shukla recently found heparan sulfate to have a regulatory 
role on cell-to-cell fusion in HeLa cells [48]. Involvement of 
syndecans in cell-to-cell spread has also been reported [39]. 
Although little is known on conformational changes that 
occur before and during fusion, unpublished data shows the 
extension of an arm towards the uninfected cell as a means 
of starting cell-to-cell fusion (O’Donnell and Shukla, 
unpublished results). Currently, very limited information is 
available on the structural details of cell fusion and 
involvement of heavy changes in cytoskeleton is highly 
suspected [15]. 
 Cell-to-cell fusion is extremely advantageous for HSV-1. 
Because HSV-1 replicates in the nucleus, syncytial cells, 
which contain multiple nuclei, formed after fusion allow 
increase in virus reproduction and spread. Additionally, 
syncytial cellsallow HSV-1 to avoid innate and adaptive 
immune defenses against the virus, which range from the 
innate mediators of mucosal immunity to antibodies and 
phagocytes that target HSV-1. However, cell-to-cell fusion 
poses few disadvantages, which include the lack of the 
ability to easily spread throughout various parts of the body. 
Normally, the release of newly replicated viruses in blood 
would allow them to quickly travel to the entire body, HSV-
1 is only rarely found in the blood [1,42]. 
CELL JUNCTIONS AND SYNAPSES IN HSV-1 
SPREAD 
 HSV-1 can also move across intercellular junctions, 
which seal adjacent epithelial cells together to prevent 
movement of small molecules and particles across barriers. 
Several factors have been found to play roles in the 
movement of HSV-1 across tight junctions, including 
glycoproteins gB, gD, gH-gL and gE-gI [42]. HSV-1 can 
bind to complexes involved in cell junctions, including 
nectin-1, an entry receptor for HSV-1 and major component 
of adherens junctions [49]. gE-gI possibly facilitates the 
attachment of HSV-1 to intercellular junctions, as the 
accumulation of gE-gI was observed to colocalize with 
junction proteins including e-cadherins of human epithelial 
cells, while it did not accrue at lateral surfaces that were not 
in contact with other cells [50]. Because movement across 
tight junctions is a form of cell-to-cell fusion, advantages 
provided by this type of cell-to-cell spread include the ability 
to avoid neutralizing antibodies and other innate and 
adaptive immune defenses. The main disadvantage is that 
cell-to-cell spread may be slower than the transport via blood 
to various parts of the body. 
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 HSV-1 can be transferred across synapses of neurons, a 
process which is not completely understood. gD, gB and gH-gL 
are always necessary for trans-neuronal spread of HSV-1. The 
virus can travel in an anterograde movement towards axon 
termini in an infected neuron and be transferred across synaptic 
space to other cells [27,42]. It is believed that gD induces the 
formation of varicosities on neurons and can be transferred 
between neurons or from the neuron to a non-neuronal cell. De 
Regge et al. found that the addition of a soluble form of PRV-
gD in neurons infected with pseudorabies virus (PRV), a 
member of the - herpesvirus family, resulted in the formation 
of varicosities in 60-70 percent of axons [51]. Also, nectin-1 
was found to play a role in the formation of varicosities, as the 
addition of the antibody CK6, which binds the ectodomain of 
nectin-1, resulted in the formation of varicosities on 70 percent 
of cells [51]. The roles of gD and nectin-1 in the formation of 
varicosities in PRV- infected cells suggests that they may also 
play a role in the formation of varicosities in HSV-infected 
cells, promoting the spread of the virus from neurons to other 
cells. 
 HSV-1 can also recruit actin-containing structures for its 
spread from cell-to-cell. Actin-containing membrane processes 
project out from the cell, contacting neighboring cells and 
allowing the movement of the virus from the protrusions to 
neighboring cells. It has been found that the viral tegument 
protein VP-16 accumulated in long protrusions from infected 
cells and that these protrusions fused with neighboring cells to 
allow the transfer of the virus from the infected to uninfected 
cell [52]. The authors suggested that these protrusions may have 
been related to actin-containing structures, which would 
indicate that VP-16 may play a role in the extension of these 
structures towards neighboring cells. 
 Because HSV-1 infects epithelial, and neuronal cells 
including those in the eyes [53], cell-to-cell spread is critical for 
its survival and ability to reach the trigeminal ganglia for the 
establishment of latency. Epithelial cells and innervating nerve 
endings usually are in close proximity with one another, 
increasing the chances of cell-to-cell spread. Also, close 
proximity increases chances of the formation of tight junctions 
and infection of neurons encourages cell-to-cell spread through 
transfer across synapses [27]. The whole thing is also likely to 
be true with HSV-2 as well, since both are highly homologous 
neurotropic viruses that commonly share entry receptors and 
other cellular mediators of virus spread including cellular 
motors for transport along the microtubules. 
 General advantages of cell-to-cell spread include evasion of 
both innate and adaptive immune responses, which range from 
the body’s physical barriers to phagocytes. For example, HSV-1 
could infect mucosal cells, while it could not penetrate the high 
viscosity mucosal membranes without cell-to-cell spread. Other 
advantages include the speed in which cells are infected after 
viral replication. Following a normal route of infection, newly 
replicated viruses would exit the cell until locating new host 
cells, a process which can consume large amounts of time, 
making the virus increasingly susceptible to immune defense 
mechanisms. As stated earlier, an advantage of the formation of 
a syncytium with multiple nuclei is advantageous for HSV-1, as 
it HSV-1 replicates in nuclei of host cells. Overall, cell-to-cell 
spread, through membrane fusion, transfer across synapses, 
recruitment of actin-containing structures, or movement across 
tight junctions, provides numerous advantages to HSV-1, 
promoting pathogenesis of the virus. It may also represent one 
of the strongest aspects of HSV-1 lifecycle that give the virus 
the ability to survive for the lifetime of its host. 
CONCLUSION 
 HSV can infect a wide variety of host cell types. One 
important reason behind this is the versatile ability of the virus 
to use multiple receptors and pathways for entry. Entry is also 
perhaps the most critical step in viral lifecycle as it allows the 
virus to initiate an infection that lasts for the lifetime of its host. 
Regardless of HSV entry receptors or pathways utilized, the 
initial infection almost always results in the establishment of 
latency. Recent advances in the field of HSV cellular receptors 
and HSV entry glycoproteins’ structures, interactions and 
functions have broadened our understanding of the pathogen. 
We are now much more knowledgeable about the identity of 
HSV entry receptors. However, more progress is needed on 
specific contributions of entry receptors, role of intracellular 
signaling in HSV entry, and characterization of molecular 
mechanisms that allow the virus to successfully evade host’s 
immune system. Such knowledge will definitely help with the 
development of new and potent HSV vaccines and anti-HSV 
drugs. It is important that the huge prevalence of HSV in the 
human population worldwide be controlled. Failing to do so will 
continue to have strong implications for not just acquiring the 
HSV-related diseases but also additional viral diseases, which 
may be facilitated by a prior infection with HSV. 
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